Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Dec 19;92(26):12416–12420. doi: 10.1073/pnas.92.26.12416

Parvovirus B19 promoter at map unit 6 confers autonomous replication competence and erythroid specificity to adeno-associated virus 2 in primary human hematopoietic progenitor cells.

X S Wang 1, M C Yoder 1, S Z Zhou 1, A Srivastava 1
PMCID: PMC40368  PMID: 8618912

Abstract

The pathogenic human parvovirus B19 is an autonomously replicating virus with a remarkable tropism for human erythroid progenitor cells. Although the target cell specificity for B19 infection has been suggested to be mediated by the erythrocyte P-antigen receptor (globoside), a number of nonerythroid cells that express this receptor are nonpermissive for B19 replication. To directly test the role of expression from the B19 promoter at map unit 6 (B19p6) in the erythroid cell specificity of B19, we constructed a recombinant adeno-associated virus 2 (AAV), in which the authentic AAV promoter at map unit 5 (AAVp5) was replaced by the B19p6 promoter. Although the wild-type (wt) AAV requires a helper virus for its optimal replication, we hypothesized that inserting the B19p6 promoter in a recombinant AAV would permit autonomous viral replication, but only in erythroid progenitor cells. In this report, we provide evidence that the B19p6 promoter is necessary and sufficient to impart autonomous replication competence and erythroid specificity to AAV in primary human hematopoietic progenitor cells. Thus, expression from the B19p6 promoter plays an important role in post-P-antigen receptor erythroid-cell specificity of parvovirus B19. The AAV-B19 hybrid vector system may also prove to be useful in potential gene therapy of human hemoglobinopathies.

Full text

PDF
12416

Images in this article

12418Fig. 2
on p.12418
12418Fig. 3
on p.12418
12419Fig. 4
on p.12419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball-Goodrich L. J., Moir R. D., Tattersall P. Parvoviral target cell specificity: acquisition of fibrotropism by a mutant of the lymphotropic strain of minute virus of mice involves multiple amino acid substitutions within the capsid. Virology. 1991 Sep;184(1):175–186. doi: 10.1016/0042-6822(91)90834-x. [DOI] [PubMed] [Google Scholar]
  2. Berns K. I., Bohenzky R. A. Adeno-associated viruses: an update. Adv Virus Res. 1987;32:243–306. doi: 10.1016/s0065-3527(08)60479-0. [DOI] [PubMed] [Google Scholar]
  3. Brown K. E., Young N. S., Liu J. M. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol. 1994 Feb;16(1):1–31. doi: 10.1016/1040-8428(94)90040-x. [DOI] [PubMed] [Google Scholar]
  4. Carter B. J. Adeno-associated virus vectors. Curr Opin Biotechnol. 1992 Oct;3(5):533–539. doi: 10.1016/0958-1669(92)90082-t. [DOI] [PubMed] [Google Scholar]
  5. Cotmore S. F., Tattersall P. Characterization and molecular cloning of a human parvovirus genome. Science. 1984 Dec 7;226(4679):1161–1165. doi: 10.1126/science.6095448. [DOI] [PubMed] [Google Scholar]
  6. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol. 1967 Jun 14;26(2):365–369. doi: 10.1016/0022-2836(67)90307-5. [DOI] [PubMed] [Google Scholar]
  7. Labow M. A., Berns K. I. The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol. 1988 May;62(5):1705–1712. doi: 10.1128/jvi.62.5.1705-1712.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Liu J. M., Fujii H., Green S. W., Komatsu N., Young N. S., Shimada T. Indiscriminate activity from the B19 parvovirus p6 promoter in nonpermissive cells. Virology. 1991 May;182(1):361–364. doi: 10.1016/0042-6822(91)90682-2. [DOI] [PubMed] [Google Scholar]
  9. Liu J. M., Green S. W., Shimada T., Young N. S. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol. 1992 Aug;66(8):4686–4692. doi: 10.1128/jvi.66.8.4686-4692.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marcus D. M., Kundu S. K., Suzuki A. The P blood group system: recent progress in immunochemistry and genetics. Semin Hematol. 1981 Jan;18(1):63–71. [PubMed] [Google Scholar]
  11. Moritz T., Patel V. P., Williams D. A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest. 1994 Apr;93(4):1451–1457. doi: 10.1172/JCI117122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nahreini P., Woody M. J., Zhou S. Z., Srivastava A. Versatile adeno-associated virus 2-based vectors for constructing recombinant virions. Gene. 1993 Feb 28;124(2):257–262. doi: 10.1016/0378-1119(93)90402-o. [DOI] [PubMed] [Google Scholar]
  13. Ozawa K., Ayub J., Hao Y. S., Kurtzman G., Shimada T., Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol. 1987 Aug;61(8):2395–2406. doi: 10.1128/jvi.61.8.2395-2406.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ozawa K., Kurtzman G., Young N. Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood. 1987 Aug;70(2):384–391. [PubMed] [Google Scholar]
  15. Ponnazhagan S., Nallari M. L., Srivastava A. Suppression of human alpha-globin gene expression mediated by the recombinant adeno-associated virus 2-based antisense vectors. J Exp Med. 1994 Feb 1;179(2):733–738. doi: 10.1084/jem.179.2.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rouger P., Gane P., Salmon C. Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies. Rev Fr Transfus Immunohematol. 1987 Dec;30(5):699–708. doi: 10.1016/s0338-4535(87)80138-1. [DOI] [PubMed] [Google Scholar]
  17. Samulski R. J., Berns K. I., Tan M., Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2077–2081. doi: 10.1073/pnas.79.6.2077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Samulski R. J., Srivastava A., Berns K. I., Muzyczka N. Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. Cell. 1983 May;33(1):135–143. doi: 10.1016/0092-8674(83)90342-2. [DOI] [PubMed] [Google Scholar]
  19. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986 Jun;58(3):921–936. doi: 10.1128/jvi.58.3.921-936.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Siegl G., Bates R. C., Berns K. I., Carter B. J., Kelly D. C., Kurstak E., Tattersall P. Characteristics and taxonomy of Parvoviridae. Intervirology. 1985;23(2):61–73. doi: 10.1159/000149587. [DOI] [PubMed] [Google Scholar]
  21. Srivastava A., Bruno E., Briddell R., Cooper R., Srivastava C., van Besien K., Hoffman R. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood. 1990 Nov 15;76(10):1997–2004. [PubMed] [Google Scholar]
  22. Srivastava A., Lusby E. W., Berns K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J Virol. 1983 Feb;45(2):555–564. doi: 10.1128/jvi.45.2.555-564.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Srivastava A. Parvovirus-based vectors for human gene therapy. Blood Cells. 1994;20(2-3):531–538. [PubMed] [Google Scholar]
  24. Srivastava A. Replication of the adeno-associated virus DNA termini in vitro. Intervirology. 1987;27(3):138–147. doi: 10.1159/000149732. [DOI] [PubMed] [Google Scholar]
  25. Srivastava C. H., Samulski R. J., Lu L., Larsen S. H., Srivastava A. Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus. Proc Natl Acad Sci U S A. 1989 Oct;86(20):8078–8082. doi: 10.1073/pnas.86.20.8078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wong S., Momoeda M., Field A., Kajigaya S., Young N. S. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein. J Virol. 1994 Jul;68(7):4690–4694. doi: 10.1128/jvi.68.7.4690-4694.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zhou S. Z., Broxmeyer H. E., Cooper S., Harrington M. A., Srivastava A. Adeno-associated virus 2-mediated gene transfer in murine hematopoietic progenitor cells. Exp Hematol. 1993 Jul;21(7):928–933. [PubMed] [Google Scholar]
  28. Zhou S. Z., Cooper S., Kang L. Y., Ruggieri L., Heimfeld S., Srivastava A., Broxmeyer H. E. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med. 1994 Jun 1;179(6):1867–1875. doi: 10.1084/jem.179.6.1867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. von dem Borne A. E., Bos M. J., Joustra-Maas N., Tromp J. F., van't Veer M. B., van Wijngaarden-du Bois R., Tetteroo P. A. A murine monoclonal IgM antibody specific for blood group P antigen (globoside) Br J Haematol. 1986 May;63(1):35–46. doi: 10.1111/j.1365-2141.1986.tb07492.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES